Esco Micro Pte. Ltd., manufacturer of some of the most innovative life science tools, has successfully raised a Series A investment of USD 200 million from a club of investors, including Vivo Capital, Novo Holdings, China Investment Corporation, K3 Ventures, and EDBI Singapore. This financing – the largest private fundraising round by an Asia-based life sciences tools company – will, amongst other things, enable Esco Micro to create an innovation hub focused on cell and gene therapy tools and technologies.
The Spice Route Legal team – led by- Mathew Chacko, acted as India counsel to the investee company. Davis Polk Waldwell acted as lead counsel to the investor.
The Legal500, the world’s largest independent legal directory, has rated Spice Route Legal as the...
Spice Route Legal is proud to announce that Chambers and Partners has, in the 2024 guides,...
We have advised Neogen Chemicals, one of India’s leading manufacturers of bromine and...
This website is owned and operated by Spice Route Legal, and is exclusively meant to be a source of information on the firm, it’s practice areas, and its members.
It is not intended and should not be construed as any form of advertisement, solicitation, invitation or inducement of any sort from the firm or its members.
Spice Route Legal does not warrant that any information provided on the website is accurate, complete or updated, and further denies liability for any and all loss or damage caused to the user as a result of their reliance on the content provided.
The information made available on this site must in no way be relied upon, or construed, as legal advice. If you need legal assistance, we recommend you seek help from competent counsel licensed to practice and advise in the relevant jurisdiction.